Aim: We aimed to evaluate the clinical utility of blood ketone measurement and to test the performance of the diagnostic criteria for diabetic ketoacidosis (DKA) issued by the American Diabetes Association, the Joint British Diabetes Societies, and the American Association of Clinical Endocrinologists and the American College of Endocrinology.
or serum bicarbonate <15 mmol/L; and ketonemia [β-hydroxybutyrate (BOHB) ≥3 mmol/L] or moderate or large ketonuria (≥2+). 3, 5 The criteria are similar to those in the UK national guidelines produced by the Joint British Diabetes Societies (JBDS), with the glycemic parameters being more flexible in the JBDS guideline (blood glucose >11 mmol/L or known diabetes mellitus). 6 The diagnostic criteria for DKA in adults issued by the American Diabetes Association (ADA) do not suggest a cutoff level for blood ketone concentration: hyperglycemia (blood glucose >13.9 mmol/L [>250 mg/dL]); arterial pH ≤7.3; serum bicarbonate ≤18 mmol/L; blood AG >10 mmol/L; and positive serum or urine ketone on a semiquantitative test. 1 Another recent statement by the American Association of Clinical Endocrinologists and the American College of Endocrinology (AACE/ACE) strongly recommended measuring blood BOHB and arterial pH to diagnose DKA with different cutoff levels for the biochemical parameters but no specific cutoff level for blood bicarbonate: arterial pH <7.3, BOHB ≥3.8 mmol/L in adults, AG >10 mmol/L, and hyperglycemia (≥250 mg/dL) or lower glycemia in specific cases. 7 However, to the best of our knowledge, there is no study to evaluate the concordance of currently available diagnostic criteria for DKA produced from different societies or to find an algorithm to better define and characterize DKA.
With regard to the measurements of ketone bodies, there are several methods to measure blood ketones with their inherent strengths and limitations: [8] [9] [10] the nitroprusside reaction method, gas chromatography-mass spectrometry (GC/MS), and enzymatic reaction methods. In addition, questions of which ketone molecule(s) [BOHB only or total ketones (BOHB and acetoacetate)] need to be measured and at what cutoff values of BOHB or total ketones DKA could be diagnosed are not clearly answered.
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In the present study, we aimed to test the performance of various DKA diagnostic criteria produced by major societies, by applying serum ketone levels and other classic parameters and to evaluate the clinical utility of blood ketone measurement. Additionally, we suggested new supplementary diagnostic criteria considering both the typical and atypical presentations of DKA, blood ketone levels, and other classic parameters.
Research design and methods

Study population and data extraction
We performed a retrospective analysis of patients who were suspected of having DKA and hospitalized between April 2014 and September 2018. We retrieved demographic, clinical, and laboratory data from electronic medical records of 381 consecutive patients at 4 university hospitals in Korea (Ajou University Hospital, CHA Bundang Medical Center, Gachon University Gil Medical Center, and Inha University Hospital). The study was approved by the institutional review board in each hospital. And, waiver of the requirement for informed consent was obtained under institutional review board regulation because of the retrospective nature of the study and the analysis used anonymous clinical data. This study followed the ethical guidelines of the Declaration of Helsinki. The data were retrieved from electronic health records of each hospital if the following conditions were met: i) clinical diagnosis of DKA or diabetes with hyperglycemia, ketosis, and symptoms suggestive of DKA; ii) simultaneous measurements of serum ketone body levels, arterial blood pH and HCO 3 − , and serum electrolytes at initial presentation. Blood glucose levels of >11 mmol/L (>200 mg/dL) and ketonemia (≥1.0 mmol/L whichever ketone was measured, regardless of urine ketone) were required to be included in the present study. Because there have been reports of differences in buffering capacity related to age, subjects aged less than 16 years were not included in the present study.
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Among the 381 patients with suspected DKA, 103 patients were excluded because of a lack of blood ketone data (n=77), other missing data related to acid-base or AG assessments (n=5), no hyperketonemia (n=4), relatively low glucose level (≤11.1 mmol/L) (n=8), or insulin and fluid therapy received just before presentation to the hospitals (n=9). The remaining 278 patients were analyzed in the present study. The biochemical data included blood glucose and hemoglobin A1C, arterial blood gas analysis, serum ketone body, blood lactate, serum creatinine and electrolytes, serum osmolality at initial presentation, and serum C-peptide levels during hospitalization. The AG and effective osmolality, delta (Δ) AG (AG -12), delta HCO 3 − (24 -HCO 3
−
) was calculated as recommended previously. 1, 12, 13 The type of diabetes (1, 2, other types, or could not determine exactly) was also determined based on all clinical and laboratory information.
The assessment and classification of diabetic patients with ketosis
Serum total ketone body (BOHB + acetoacetate) measurement was performed by using an enzymatic method, We used the ketosis and ketoacidotic criteria for serum ketone levels instead of semi-quantitative urine or serum ketone readings. 8 
Results
Characteristic categories of DKA by different guidelines
Based on the initial presentation patterns, 278 patients with suspected DKA were classified into 4 subgroups by the major guidelines and our supplementary criteria. Although ketosis (n=23) and significant lactic acidosiscombined DKA (n=28) were defined concordantly based on our strategy, there was a significant variation in the diagnosis of typical DKA by those guidelines if applied in a strict manner. Thus, many patients escaped an exact classification by the 3 major guidelines and were diagnosed with atypical DKA by applying our supplementary criteria ( Figure 1 ). Table 1 summarizes the 4 categories according to initial presentation by the ADA criteria and by our supplementary criteria. Accordingly, 23 patients (8.3%) were diagnosed with diabetic ketosis but not DKA ( Table 1 ). The characteristics of the patients with typical and atypical presentations judged by the JBDS and AACE/ACE criteria are also presented in Tables S1 and S2, respectively.
The range of blood ketone levels in patients with ketosis was 1.05-5.13 mmol/L, showing a huge variation of blood ketone levels even at a simple ketotic state. Five patients (21.7%) among 23 ketotic patients had a ketone level of 3 mmol/L or more.
Careful interpretation of biochemical data is required to not miss DKA with atypical presentation
Based on the ketotic levels of blood ketone and other classic parameters, the strict application of the ADA criteria did not correctly define DKA in 46 (16.5%) patients Figure 1 The classification of patients with suspected DKA according to their initial presentations by three major diagnostic recommendations issued from the American Diabetes Association (ADA), the Joint British Diabetes Societies (JBDS), and the American Association of Clinical Endocrinologists and the American College of Endocrinology (AACE/ACE), respectively, and our supplementary criteria. Atypical DKA in each classification was considered if biochemical data did not meet each set of diagnostic criteria issued by each society, respectively, but met our supplementary criteria. The proportions of missed patients (atypical DKA by our supplementary criteria) were significantly different between the three societies (P<0.01 in all sets of between-society comparisons using the chi-squared test). 1 and  Tables S1 and S2 ). The proportions of missed patients (atypical DKA by our supplementary criteria) were significantly different between the three societies (P<0.01 in all sets of between-society comparisons using the chisquared test) ( Figure 1 ). As shown in Table 1 , S1 and S2, compared with patients with typical DKA, patients with an atypical DKA presentation were more likely to have lower ketone body levels and slightly less deranged acid-base homeostasis with a tendency to be type 2 diabetics and to have higher fasting C-peptide levels. However, the inhospital mortality rate was comparable between the two groups across the three tabulations. Among the ketotic patients, one patient (72-year-old male patient) died during hospitalization due to an accidental fall and subsequent complications, suggesting that the actual ketosis mortality is zero in this subgroup (Table 1) .
DKA combined with significant lactic acidosis requires early detection and intensive treatment
Blood lactate levels were available in 274 patients. When we categorized these patients into three groups according to the lactate level (≤2.0 mmol/L, from >2.0-5.0 mmol/L, >5.0 mmol/L). The in-hospital mortality rate was significantly higher only in the group with lactate levels >5 mmol: 3/121 (2.5%), 7/125 (5.6%), and 8/28 (28.6%), respectively (P<0.01). This subgroup with high risk did not escape from the definition regardless of which guidelines were applied to diagnose DKA ( Figure 1 and Table 1 ). Importantly, this DKA + lactic acidosis group was associated with a mortality of more than 7 times the mortality of the combined typical and atypical DKA groups (28.6% vs 4.0%, P<0.01) ( Table 2) . Compared with the 2 combined DKA groups, this high risk group was more likely to be older and had a lower diastolic blood pressure; lower serum levels of sodium, potassium, and chloride ions; lower hemoglobin, platelet count, arterial pH, and hemoglobin A1c; and higher levels of the AG (Table 2) .
Correlations between blood ketone and bicarbonate and other parameters
Blood ketone levels showed a negative correlation with blood bicarbonate level (r = −0.308, P<0.01), blood pH (r= −0.240, P<0.01), and serum fasting C-peptide (r = −0.195, P<0.01) and a positive correlation with blood AG (r =0.321, P<0.01). We also defined the total ketone values corresponding to HCO 3 − levels of 18 mmol/L by linear regression analysis.
The values were between 4.5 and 5.8 mmol/L across analytic methods and the kind of ketone body measured.
Independent factors associated with mortality
The causes of death the were infection/sepsis (n=5), cerebrovascular accident (n=2), gastrointestinal bleeding (n=1), fall and related complications (n=1), and undifferentiated shock (n=9) among the 278 patients. Univariate analysis showed that age, systolic and diastolic blood pressures, serum creatinine and blood lactate were independent predictors of mortality. In multiple logistic regression analysis, age and blood lactate were independently associated with the in-hospital mortality: the ORs (95% CIs, P-values) were 1.040 (1.006-1.075, P<0.05) and 1.275 (1.132-1.435, P<0.01), respectively (Table 3) .
Discussion
In the present study, we found that a single cutoff level of blood ketone concentration could not precisely define diabetic ketosis or DKA in diabetic patients because of the wide variation of blood ketone levels. In addition, if each set of diagnostic criteria for DKA produced by the ADA, JBDS, and AACE/ACE were applied strictly and separately, 16.5-42.4% of patients with suspected DKA may escape from the diagnosis of DKA depending on initial presentation patterns and diagnostic criteria. We observed that the AACE/ACE diagnostic criteria might perform most poorly due to the omission of the bicarbonate criterion and the use of a higher cutoff level for BOHB in the diagnostic criteria. 7 Although it is a seemingly milder form of DKA, patients with atypical DKA had similar in-hospital mortality rates as patients with typical DKA. In addition, the current ADA classification of mild, moderate, and severe categories of DKA is not easy to apply to DKA patients because significant proportions of patients presented with variable clinical characteristics, including increasing type 2 diabetes, beta-cell function, mixed acid-base disorders, SGLT2 inhibitor therapy, or others.
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The results suggest that more careful interpretation in patients with suspected DKA as well as in patients with apparent ketotic presentation are required to not miss the diagnosis of DKA. In contrast, DKA patients with significant lactic acidosis or patients with diabetic ketosis could be categorized concordantly in the present study by applying each society guideline and our supplementary criteria simultaneously.
Among the three ketone molecules (acetoacetate, BOHB, and acetone), BOHB is a principal ketone body. 8 The BOHB/acetoacetate ratio is normally approximately 1, and the ratio is increased in various pathophysiologic states, most notably in DKA, up to 3~10:1. 14 However, the measurement of both BOHB and acetoacetate may capture the clinical status of DKA more precisely and may be useful for both the diagnosis and follow-up of DKA. In the present study, the majority of our ketone data were based on the total ketone levels, except for 20 cases with BOHB data. Our results showed that diabetic ketosis patients have blood ketone levels of 1.05-5.13 mmol/L, with 21.7% of ketotic patients having a blood ketone level of 3 mmol/L or more. If all the DKA patients (typical, atypical, and lactic acidosis-combined, n=255) were analyzed together, blood ketone levels ranged from 1.02-15.9 mmol/L, with approximately 30% of patients having less than 3.0 mmol/L. Because the BOHB levels were measured in a hospital (n=20), we compared the total ketone levels from other 3 hospitals (n=235) and the BOHB levels from this hospital. The distributions of ketone body levels were similar: total ketone, median level 4.0 with interquartile range (IQR) 2.90-7.50 mmol/ L; and BOHB median (IQR) 4.2 (2.8-5.82) mmol/L. Our study showed that simple mechanical application of a cutoff level of blood ketone body concentration for the diagnosis of DKA would be problematic. Additionally, it is becoming more popular to measure blood ketone bodies using point-of-care (POC) ketone meters, automatic enzymatic analyzers, or GC/MS in various clinical environments. Thus, ketone body measurement, including methods, types of ketones measured, and standardization, also needs to be studied further to better define DKA. Although there have been several guidelines related to DKA, much of the information for guideline or diagnostic criteria development was from data on which studies were performed more than 20-30 years ago, when semi-quantitative blood or urine ketone measurements were the only or the usual measures to check the ketone body level. 17 Few amendments to diagnostic criteria or few attempts to develop a unifying and updated guideline have been made until now, despite there have been many changes in the characteristics of DKA patients and technical advances in diabetes management and ketone measurement. 15, 18 In addition, there have been significant gaps between the definition of metabolic acidosis and the diagnostic criteria of DKA: for blood pH levels 7.35 vs 7.30, respectively; and for bicarbonate, usually 22 mmol/L vs 15 or 18 mmol/L, respectively, 1, 6, 7, 13, 19 with the terms "and", "or", and "and/or" being used when interpreting pH and bicarbonate data. The AACE/ACE guideline recommends not using bicarbonate data for DKA diagnosis, 7 while the JBDS guideline does not include the AG cutoff criterion, but sets a lower bicarbonate cutoff level. 6 The ADA and AACE/ACE set the cutoff level of the AG at 10 mmol/L for DKA diagnosis. 1 However, the reference ranges of the AG are wide, depending on the laboratory (3-12 mmol/L). 13, 20 In certain presentations with DKA, normal values for concentrations of bicarbonate, PaCO 2 , and pH level do not ensure the absence of an acid-base disturbance. An increase in the AG of >5 mmol per liter above the upper normal limit may then be the only clue to an underlying mixed acid-base disorder. 12, 13 Or ΔAG -ΔHCO 3 − may be calculated to identify a mixed acid-base disorder or normal AG metabolic acidosis as reviewed previously. 13 Various medical conditions accompanying DKA may not allow simple interpretations of pH, bicarbonate, and the AG values, requiring more flexible application of the criteria and careful interpretation of the biochemical results; for example, a normal AG (diarrhea, maintained water and salt intake, or renal dysfunction) or metabolic alkalosis (vomiting, volume depletion, the use of diuretics, or hypokalemia).
12,13,21
Lactic acidosis is frequently observed in DKA patients, with a variable impact on prognosis, depending on the definition. 19 A previous study showed that increases in blood lactate levels of >2.5 mmol/L and >4 mmol/L were observed in more than two-thirds and in 40%, respectively, of DKA patients without a significant impact on mortality. 22 However, our results showed that blood lactate >5 mmol/L in DKA was associated with a mortality rate more than 7 times higher than the mortality rate associated with a lactate level ≤5 mmol/L (28.6% vs 4.0%, respectively). Our results suggest that DKA patients should be routinely tested for blood lactate. Additionally, all patients with DKA and elevated lactate levels must have an estimation of relevant comorbid conditions and DKA triggers (renal function, infections, sepsis, and others). Considering our findings of a broad range of blood ketone levels in DKA patients, the need for systematic interpretation of biochemical data, including the pH level, bicarbonate, and the AG, in patients with a mixed acid-base disorder, and a high mortality in patients accompanying significant lactic acidosis, we suggest a new algorithm for DKA diagnosis (Figure 2 ).
There are several limitations in the present study. First, the present study is a retrospective study based on electronic medical records. Second, although we measured BOHB and acetoacetate in the majority of patients, some patients have measured BOHB using POC ketone meters in a hospital. Notably, there are few data on the combined measurements of the sum of BOHB and acetoacetate using enzymatic automatic analyzers, although widely available. Third, although we have suggested supplementary criteria to detect DKA with mixed acid-base disorders, we did not prove the performance of our supplementary criteria using an independent DKA cohort. Fourth, we excluded patients with relatively low hyperglycemia (so-called euglycemic DKA or ketosis) to compare 3 different diagnostic criteria for our convenience. There were 7 patients with euglycemic DKA and 1 patient with ketosis, where sodium-glucose cotransporter 2 (SGLT2) inhibitors were not involved, except for one patient whose drug information was not available. Euglycemic DKA has been reported to be associated with various factors as well as with recently available SGLT2 inhibitors. 23, 24 Thus, this trait also needs to be studied further. Fifth, our study involved only a single population. There may be some inter-ethnic variation in the characteristics of DKA patients, including the degree of acidosis and type of diabetes. 15, 16 In conclusion, our results suggest that due to variable presentations and a wide range of blood ketone levels in DKA, a new system is required to better characterize DKA and to supplement current diagnostic criteria for DKA issued by major societies.
Summary
• The clinical parameters and criteria issued by major societies for the diagnosis of DKA are not concordant and blood ketone measurement is not standardized yet despite various analytic methods and options became available.
• We found that there were significant discrepancies between 3 major society guidelines in detecting DKA if applied strictly and that a single cutoff level of blood ketone could not be applied for the diagnosis of DKA because of wide variation of blood ketone levels and variable presentation of DKA.
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